{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Propanc Biopharma, Inc."},"Symbol":{"label":"Symbol","value":"PPCB"},"Address":{"label":"Address","value":"302, 6 BUTLER STREET, CAMBWERWELL, 3124, Australia"},"Phone":{"label":"Phone","value":"+61 398820780"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Australia and South Pacific"},"CompanyDescription":{"label":"Company Description","value":"Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes."},"CompanyUrl":{"label":"Company Url","value":"https://www.propanc.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}